Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariette Barbier

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Plos One|November 2, 2023
Intranasal challenge with B. pertussis leads to more severe disease manifestations in mice than aerosol challengeKelly L Weaver, Graham J Bitzer, M Allison Wolf, et al.
NPJ Vaccines|March 15, 2022
Intranasal administration of BReC-CoV-2 COVID-19 vaccine protects K18-hACE2 mice against lethal SARS-CoV-2 challengeTing Y Wong, Katherine S Lee, Brynnan P Russ, et al.
Frontiers in Immunology|September 12, 2022
Passive immunization with equine RBD-specific Fab protects K18-hACE2-mice against Alpha or Beta variants of SARS-CoV-2Mariette Barbier, Katherine S Lee, Mayur S Vikharankar, et al.
Journal of Virology|January 26, 2022
Evaluating Antibody Mediated Protection against Alpha, Beta, and Delta SARS-CoV-2 Variants of Concern in K18-hACE2 Transgenic MiceTing Y Wong, Alexander M Horspool, Brynnan P Russ, et al.
Microbiology Spectrum|June 1, 2026
Development of a fluorescent reporter strain to facilitate studies of <i>Borrelia burgdorferi</i> pathogenesisAnnalisa B Huckaby, Maria de la Paz Gutierrez, Ching Wooen Sze, et al.
NPJ Vaccines|June 10, 2024
Multivalent mRNA-DTP vaccines are immunogenic and provide protection from Bordetella pertussis challenge in miceM Allison Wolf, Joanne M O'Hara, Graham J Bitzer, et al.
Frontiers in Cellular and Infection Microbiology|May 1, 2023
Development of an anti-<i>Pseudomonas aeruginosa</i> therapeutic monoclonal antibody WVDC-5244Alexander M Horspool, Emel Sen-Kilic, Aaron C Malkowski, et al.
Infection and Immunity|December 13, 2024
Novel broadly reactive monoclonal antibody protects against <i>Pseudomonas aeruginosa</i> infectionMargalida Mateu-Borrás, Spencer R Dublin, Jason Kang, et al.
Msphere|August 15, 2022
RBD-VLP Vaccines Adjuvanted with Alum or SWE Protect K18-hACE2 Mice against SARS-CoV-2 VOC ChallengeTing Y Wong, Brynnan P Russ, Katherine S Lee, et al.
Vaccine|January 7, 2023
Molecular engineering of a cryptic epitope in Spike RBD improves manufacturability and neutralizing breadth against SARS-CoV-2 variantsSergio A Rodriguez-Aponte, Neil C Dalvie, Ting Y Wong, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Plos One|November 2, 2023
Intranasal challenge with B. pertussis leads to more severe disease manifestations in mice than aerosol challengeKelly L Weaver, Graham J Bitzer, M Allison Wolf, et al.
NPJ Vaccines|March 15, 2022
Intranasal administration of BReC-CoV-2 COVID-19 vaccine protects K18-hACE2 mice against lethal SARS-CoV-2 challengeTing Y Wong, Katherine S Lee, Brynnan P Russ, et al.
Frontiers in Immunology|September 12, 2022
Passive immunization with equine RBD-specific Fab protects K18-hACE2-mice against Alpha or Beta variants of SARS-CoV-2Mariette Barbier, Katherine S Lee, Mayur S Vikharankar, et al.
Journal of Virology|January 26, 2022
Evaluating Antibody Mediated Protection against Alpha, Beta, and Delta SARS-CoV-2 Variants of Concern in K18-hACE2 Transgenic MiceTing Y Wong, Alexander M Horspool, Brynnan P Russ, et al.
Microbiology Spectrum|June 1, 2026
Development of a fluorescent reporter strain to facilitate studies of <i>Borrelia burgdorferi</i> pathogenesisAnnalisa B Huckaby, Maria de la Paz Gutierrez, Ching Wooen Sze, et al.
NPJ Vaccines|June 10, 2024
Multivalent mRNA-DTP vaccines are immunogenic and provide protection from Bordetella pertussis challenge in miceM Allison Wolf, Joanne M O'Hara, Graham J Bitzer, et al.
Frontiers in Cellular and Infection Microbiology|May 1, 2023
Development of an anti-<i>Pseudomonas aeruginosa</i> therapeutic monoclonal antibody WVDC-5244Alexander M Horspool, Emel Sen-Kilic, Aaron C Malkowski, et al.
Infection and Immunity|December 13, 2024
Novel broadly reactive monoclonal antibody protects against <i>Pseudomonas aeruginosa</i> infectionMargalida Mateu-Borrás, Spencer R Dublin, Jason Kang, et al.
Msphere|August 15, 2022
RBD-VLP Vaccines Adjuvanted with Alum or SWE Protect K18-hACE2 Mice against SARS-CoV-2 VOC ChallengeTing Y Wong, Brynnan P Russ, Katherine S Lee, et al.
Vaccine|January 7, 2023
Molecular engineering of a cryptic epitope in Spike RBD improves manufacturability and neutralizing breadth against SARS-CoV-2 variantsSergio A Rodriguez-Aponte, Neil C Dalvie, Ting Y Wong, et al.
Pageof 8